The metabolic consequences of CPS1 and CAD alterations were investigated through the construction of a network combining urea cycle and the de novo pyrimidine biosynthesis pathways, two of the many metabolic pathways which are thought to play a role in the development of HCC. This evidence concerns the gene CPS1 and hepatocellular carcinoma.